{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:10:54Z","timestamp":1780956654057,"version":"3.54.1"},"reference-count":42,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Reumafonds","award":["Novartis research grant"],"award-info":[{"award-number":["Novartis research grant"]}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Interleukin\u201017A (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A) and tumor necrosis factor (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>) contribute to the pathogenesis of psoriatic arthritis (PsA). However, their functional relationship in PsA synovitis has not been fully elucidated. Additionally, although <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells in PsA have been recognized via flow cytometry as a source of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A production, it is not clear whether <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells secrete <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A under more physiologically relevant conditions in the context from PsA synovitis. This study was undertaken to clarify the roles of <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A and <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content> in the synovial fluid (<jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>) from patients with PsA and investigate the impact of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells on <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A production.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A+ T cells were identified by flow cytometry in <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> samples from 20 patients with active PsA, blood samples from 22 treatment\u2010naive patients with PsA, and blood samples from 22 healthy donors. <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A+ T cells were sorted from 12 PsA <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> samples and stimulated using anti\u2010<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>3\/anti\u2010<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>28 or phorbol myristate acetate (<jats:styled-content style=\"fixed-case\">PMA<\/jats:styled-content>) and ionomycin ex vivo, alone (n = 3) or together with autologous monocytes (n = 3) or PsA fibroblast\u2010like synoviocytes (<jats:styled-content style=\"fixed-case\">FLS<\/jats:styled-content>) (n = 5\u20136). To evaluate the differential allogeneic effects of neutralizing <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A and <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> SF CD<\/jats:styled-content>4+ T cells and PsA <jats:styled-content style=\"fixed-case\">FLS<\/jats:styled-content> cocultures were also used (n = 5\u20136).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Flow cytometry analyses of <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> samples from patients with PsA showed IL\u201017A positivity for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4+ and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A, median 0.71% [interquartile range 0.35\u20131.50%] in <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4+ cells; median 0.44% [interquartile range 0.17\u20131.86%] in <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells).<\/jats:p><jats:p>However, only <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4+ T cells secreted <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A after anti\u2010<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>3\/anti\u2010<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>28 activation, when cultured alone and in cocultures with PsA monocytes or PsA <jats:styled-content style=\"fixed-case\">FLS<\/jats:styled-content> (each <jats:italic>P<\/jats:italic> &lt; 0.05). Remarkably, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells only secreted <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A after 4\u2010 or 72\u2010hour stimulation with <jats:styled-content style=\"fixed-case\">PMA<\/jats:styled-content>\/ionomycin. Anti\u2013<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A and anti\u2010<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content> treatments both inhibited PsA synovitis ex vivo. Neutralizing <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A strongly inhibited <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106 (<jats:italic>P<\/jats:italic> &lt; 0.05) and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20101\u03b2 (<jats:italic>P<\/jats:italic> &lt; 0.01), while anti\u2010<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content> treatment was more potent in reducing matrix metalloproteinase 3 (<jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\u20103) (<jats:italic>P<\/jats:italic> &lt; 0.05) and <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>\u201013.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells, in contrast to <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4+ T cells, in <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> specimens obtained from PsA patients did not secrete <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A following T cell receptor activation. Overlapping, but distinct, effects at the level of inflammatory cytokines and <jats:styled-content style=\"fixed-case\">MMP<\/jats:styled-content>s were found after neutralizing <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017A or <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content> ex vivo in a human model of PsA synovitis.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.41271","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T12:21:31Z","timestamp":1585916491000},"page":"1303-1313","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Interleukin\u201017A Is Produced by CD4+ but Not CD8+ T Cells in Synovial Fluid Following T Cell Receptor Activation and Regulates Different Inflammatory Mediators Compared to Tumor Necrosis Factor in a Model of Psoriatic Arthritis Synovitis"],"prefix":"10.1002","volume":"72","author":[{"given":"Xiaofei","family":"Xu","sequence":"first","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Davelaar","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Marie","family":"Mus","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Asmawidjaja","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M. W.","family":"Hazes","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique L. P.","family":"Baeten","sequence":"additional","affiliation":[{"name":"Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn","family":"Vis","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radjesh J.","family":"Bisoendial","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol P.","family":"Prens","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-040X","authenticated-orcid":false,"given":"Erik","family":"Lubberts","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1985.tb01931.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.11.1112"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2878"},{"key":"e_1_2_6_6_1","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor\u2010\u03b1 and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch G","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_6_7_1","first-page":"1544","article-title":"Patterns of cytokine production in psoriatic synovium","volume":"25","author":"Ritchlin C","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0426-z"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-009-0189-9"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2017.17037"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-1036-6"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214138"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38376"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47310-5"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41156"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39261"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40736"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.4.298"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.09.005"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13561"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39685"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209709"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0084-0"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31429-0"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30093"},{"key":"e_1_2_6_28_1","first-page":"1117","article-title":"Predominance of CD8+ T lymphocytes in psoriatic arthritis","volume":"26","author":"Costello P","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1189\/JLB.0109046"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014108"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key173"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40579"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38896"},{"key":"e_1_2_6_35_1","first-page":"389","article-title":"Natural killer cells and \u03b3\/\u03b4 T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis","volume":"22","author":"Spadaro A","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.04.010"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10410"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22811"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-076364"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00070-4"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.53"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204741"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30952-8"}],"updated-by":[{"DOI":"10.1002\/art.41617","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T00:00:00Z","timestamp":1609027200000}}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.41271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.41271","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:26:36Z","timestamp":1759947996000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.41271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/art.41271"],"URL":"https:\/\/doi.org\/10.1002\/art.41271","archive":["Portico"],"relation":{"erratum":[{"id-type":"doi","id":"10.1002\/art.41617","asserted-by":"object"}]},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"2019-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}